Health Care/Hospital

Expediting R&D Digitization for Life Sciences, ArisGlobal Introduces LifeSphere® NavaX™ - The Next-Generation Cognitive Computing Engine

NavaX will revolutionize the end-to-end Research and Development processes with the latest advanced technologies BOSTON, Dec. 15, 2023 /PRNewswire/ -- ArisGlobal, a market leader in Life Sciences technology and the creator of LifeSphere®, has today launched LifeSphere NavaX, a cutting-edge cogni...

2023-12-15 04:01 1657

Lunit to Acquire Volpara: Scheme Implementation Agreement Signed

- Lunit's strategic global leap: to acquire all of Volpara shares at AUD 1.15 per share, envisioning completion by Q2 2024 SEOUL. South Korea, Dec. 14, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced ...

2023-12-14 22:05 1303

Dain Leaders Provides a Lively Practice Environment with 'HAIO', a VR Medical Education Contents

SEOUL, South Korea, Dec. 14, 2023 /PRNewswire/ -- Dain Leaders, an edutech company, is expanding its scope of contents business to actively respond the increasing metaverse market demand and lead the digital transformation in the medical, educational, and public sectors.

2023-12-14 22:00 1912

China Jo-Jo Drugstores Granted A Second Extension to Meet Nasdaq Minimum Bid Price Requirement

HANGZHOU, China, Dec. 14, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) (the "Company"), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that on December 13, 2023, t...

2023-12-14 21:30 3281

Titans Gather, Future Embarks: The GenScript Biotech Global Forum coinciding with the 2024 J.P. Morgan Healthcare Conference in San Francisco to Convene 20+ KOLs, Exploring Disruptive Transformations and Infinite Opportunities in GCT

Keynote speaker Peter Marks to Deliver Address  Free Early Bird Registration Closing Soon NANJING, China, Dec. 14, 2023 /PRNewswire/ -- Technological advancements continuously empower the life sciences. Gene and cell therapy (GCT), as breakthrough treatments, are turning the once-unreachable dre...

2023-12-14 20:34 2178

BD to become exclusive global license partner (excluding China) for Bactiguard coated Foley catheters

STOCKHOLM, Dec. 14, 2023 /PRNewswire/ -- Bactiguard Holding AB (publ.) today announces strengthened ties with leading global medical technology company Becton Dickinson & Company (BD), Bactiguard's longest and strongest license collaboration. An interim agreement has been signed granting BD an exc...

2023-12-14 17:53 1386

Vantage Foundation's Wishing Well Initiative Brings Joy To Rumah Hope Children's Home In Malaysia

PETALING JAYA, Malaysia, Dec. 14, 2023 /PRNewswire/ -- This holiday season, Vantage Foundation is lighting up the lives of underprivileged youth at Rumah Hope Children's Home inMalaysia with a heartwarming initiative designed to foster sensitivity and inclusivity during festive holidays. The "...

2023-12-14 17:05 1699

Fosun Pharma's Global Multi-Center Phase III Clinical Trial Project for A New Antimalarial Drug Receives 500 Million Japanese Yen Investment from GHIT Fund to Jointly Improve the Global Accessibility of Antimalarial Drugs

SHANGHAI, Dec. 14, 2023 /PRNewswire/ -- The Japan-based Global Health Innovative Technology Fund (GHIT Fund) announced today that it will invest approximatelyUS$3.3 million (approximately 500 million yen[1]) in a global multicenter Phase III clinical trial project (the "Program") led by Fosun Ph...

2023-12-14 17:00 3503

MGI Australia unveils its CEC with DCS Lab products featuring pioneering technology in DNA, Cell, and Spatial-omics Technology

Australia first market outside China to access revolutionary new capability BRISBANE, Australia, Dec. 14, 2023 /PRNewswire/ -- MGI Australia, a subsidiary ofMGI Tech Co. Ltd. (MGI), a global leader i...

2023-12-14 13:13 1853

Pretty Beauty Group Leads the Beauty Tech Trend with the Introduction of LDM Triple 19

HONG KONG, Dec. 14, 2023 /PRNewswire/ -- Pretty Beauty Group once again demonstrates its commitment to leading the market by introducing a revolutionary beauty device - LDM Triple 19. This groundbreaking technology, known as the LDM® Skin Cell Regeneration Device, has been meticulously developed...

2023-12-14 12:27 1389

Antengene Announces Inclusion of XPOVIO® (selinexor) in 2023 China's National Reimbursement Drug List

SHANGHAI and HONG KONG, Dec. 14, 2023 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cance...

2023-12-14 09:55 1630

The Inaugural Fosun Health Conference on Guangdong-Hong Kong-Macao Healthcare Development Integration Held in Hong Kong to Promote "Three Links" Development

HONG KONG, Dec. 14, 2023 /PRNewswire/ -- The Inaugural Fosun Health Conference onGuangdong-Hong Kong-Macao Healthcare Development Integration was successfully held inHong Kong by Fosun Health on December 12, 2023. With the background of integrating medical services ofGuangdong, Hong Kong and Maca...

2023-12-14 09:00 3480

Abbisko Therapeutics Announces that U.S. FDA Has Granted Fast Track Designation for Its CSF-1R Inhibitor Pimicotinib (ABSK021)

SHANGHAI, Dec. 13, 2023 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics") today announced that its CSF-1R inhibitor pimicotinib (ABSK021) has been granted the fast track designation ("FTD") by the U.S. FDA for the treatment of tenosynovial giant cell tumor ("TGCT") patients ...

2023-12-14 08:30 1334

Crown Aesthetics Announces Groundbreaking Study on Skin Microbiome-Optimized BIOJUVE™ Regimen

Study Reveals Remarkable Results in Aesthetic Treatment Recovery DALLAS, Dec. 14, 2023 /PRNewswire/ -- Crown Aesthetics, a Crown Laboratories, Inc. company ("Crown"), announced today that its groundbreaking clinical study, recently accepted for publication in the Journal of Clinical and Aesthetic...

2023-12-14 03:56 1363

GREATER DES MOINES PARTNERSHIP ANNUAL DINNER SPEAKER ANNOUNCED

GREATER DES MOINES, Iowa, Dec. 13, 2023 /PRNewswire/ -- The Greater Des Moines Partnership has announced that its 2024 Annual Dinner will take place on Thursday, Jan. 25, 2024 at the Community Choice Credit Union Convention Center. The Partnership's Annual Dinner is the Greater Des Moines (DSM) bu...

2023-12-13 22:30 1388

COP28: Angel Yeast's Environmentally Friendly Yeast Protein Empowers Sustainability Development

SHANGHAI, Dec. 13, 2023 /PRNewswire/ -- Angel Yeast , (SH600298), the world's leading yeast manufacturer, is responding to the call of action ofCOP28 which is taking place from November 30 to December 12 in Dubai with concrete actions and sustainable solutions.

2023-12-13 22:04 2300

Immunocan Provides Update on Business Operations, Highlighting Launch of New Gene-edited Mice Generating Fully Human Heavy-chain-only Antibodies and Advances in Partner Pipeline

SHANGHAI, Dec. 13, 2023 /PRNewswire/ -- Shanghai Immunocan Biotech Co., Ltd. ("Immunocan") announcesthe launch of its ImmuMab Heavy® mice. These gene-edited mice, developed by modifying the constant region genes of heavy chains in the ImmuMab® mouse, generate fully human heavy-chain-only antibodi...

2023-12-13 22:00 1520

WAT Medical Joins World's Largest Boat Show

VANCOUVER, BC, Dec. 13, 2023 /PRNewswire/ -- Discover Boating Miami International Boat Show (DBMIBS) is the world's largest boat and yacht show. The convention, which attracts over 100,000 visitors from more than 35 countries, provides an opportunity for aquatic innovations and consumer products...

2023-12-13 22:00 1265

Virtual twin to improve treatment with cancer immunotherapies

COLOGNE, Germany, Dec. 13, 2023 /PRNewswire/ -- An international team started the research project CERTAINTY inDecember 2023. Together with partners from science, industry and the healthcare sector, the project team led by the Fraunhofer Institute for Cell Therapy and Immunology IZI aims to devel...

2023-12-13 21:06 1159

Alebund Reports Update for AP306 (EOS789), a First-in-Class Pan-inhibitor of Sodium-dependent Phosphate Transporters, from a Completed Phase II Clinical Trial in Patients with Hyperphosphatemia on Hemodialysis

SHANGHAI, Dec. 13, 2023 /PRNewswire/ -- Alebund Pharmaceuticals  ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for the treatment of renal diseases and related chronic conditions, announcedphase II proof-...

2023-12-13 21:00 1428
1 ... 51525354555657 ... 807